Cargando…
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Pancreatic cancer has a high mortality rate and its incidence has risen rapidly in recent years. Meanwhile, the diagnosis and treatment of this cancer remain challenging. Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, but, currently, no sufficiently effective m...
Autores principales: | Wu, Chu, Yang, Ping, Liu, Bingxue, Tang, Yunlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108878/ https://www.ncbi.nlm.nih.gov/pubmed/32273725 http://dx.doi.org/10.2147/OTT.S232464 |
Ejemplares similares
-
CDKN2A-Inactivated Pancreatic Ductal Adenocarcinoma Exhibits Therapeutic Sensitivity to Paclitaxel: A Bioinformatics Study
por: Lin, Jiunn-Chang, et al.
Publicado: (2020) -
Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus
por: Tang, Zhen-Chu, et al.
Publicado: (2020) -
Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019) -
Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013) -
Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)